C. Michelet

发表

Adherence to and Effectiveness of Highly Active Antiretroviral Treatment for HIV Infection: Assessing the Bidirectional Relationship

J. Moatti, K. Lamiraud, F. Raffi, 2012, Medical care.

Introduction of SARS in France, March–April, 2003

Bruno Hoen, Yves Mouton, Sylvie van der Werf, 2004, Emerging infectious diseases.

New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virus.

P. André, C. Michelet, R. Colimon, 1996, Journal of virological methods.

Impact of Early versus Late Adherence to Highly Active Antiretroviral Therapy on Immuno-Virological Response: A 3-Year Follow-Up Study

J. Moatti, F. Raffi, M. Carrieri, 2002, Antiviral therapy.

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

H. Fleury, F. Raffi, C. Michelet, 2002, The Journal of infectious diseases.

Efficacy and Tolerability of a Nucleoside Reverse Transcriptase Inhibitor-Sparing Combination of Lopinavir/Ritonavir and Efavirenz in HIV-1-Infected Patients

F. Raffi, C. Michelet, C. Brunet-François, 2005, Journal of acquired immune deficiency syndromes.

Imported Crimean-Congo Hemorrhagic Fever

C. Michelet, H. Zeller, A. Tarantola, 2005, Journal of Clinical Microbiology.

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults

Y. Lévy, C. Michelet, F. Lucht, 2013, AIDS.

Salvage therapy with amprenavir and ritonavir: Prospective study in 17 heavily pretreated patients

C. Michelet, P. Tattevin, C. Arvieux, 2002, HIV clinical trials.

Amplification of the Six Major Human Herpesviruses from Cerebrospinal Fluid by a Single PCR

C. Michelet, R. Colimon, S. Minjolle, 1999, Journal of Clinical Microbiology.

Decision making system.

M Sobesky, C Michelet, R Thomas, 1994, Journal of clinical computing.

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

F. Carrat, C. Michelet, D. Guyader, 2010, Journal of hepatology.

Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases.

C. Michelet, A. Devillers, P. Tattevin, 2014, Medecine et maladies infectieuses.

Intérêt diagnostic des TEP-TDM en infectiologie [Contribution of 18fluoro-deoxyglucose PET/CT for the diagnosis of infectious diseases.]

C. Michelet, A. Devillers, P. Tattevin, 2014 .

Vertebral osteomyelitis presenting as exudative pleural effusion.

C. Michelet, P. Tattevin, S. Jouneau, 2004, European journal of internal medicine.

A retrospective study of 230 consecutive patients hospitalized for presumed travel-related illness (2000–2006)

C. Michelet, P. Tattevin, C. Arvieux, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients

P. Morlat, F. Raffi, C. Michelet, 1997, AIDS.

Influence of job seniority, hand hygiene education, and patient-to-nurse ratio on hand disinfection compliance.

E. Leray, C. Michelet, M. Bonnaure-Mallet, 2010, The Journal of hospital infection.

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.

C. Katlama, C. Michelet, G. Chêne, 2009, The Journal of antimicrobial chemotherapy.

Assessment of Interindividual Variability of Plasma Concentrations after Administration of High Doses of Intravenous Amoxicillin or Cloxacillin in Critically Ill Patients

C. Michelet, P. Tattevin, M. Verdier, 2011, Journal of chemotherapy.

Inhibition of intracellular growth of Listeria monocytogenes by antibiotics

C. Michelet, P. Berche, F. Cartier, 1994, Antimicrobial Agents and Chemotherapy.

Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal.

F. Raffi, C. Michelet, C. Leport, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of high-performance liquid chromatography (HPLC) to monitor beta-lactam plasma concentrations during the treatment of endocarditis.

C. Michelet, Y. le Tulzo, P. Tattevin, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.

E. Donal, C. Michelet, F. Lemaitre, 2014, Medecine et maladies infectieuses.

Clostridium difficile infections: do we know the real dimensions of the problem?

C. Michelet, P. Tattevin, P. Donnio, 2013, International journal of antimicrobial agents.

Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction

K. Tarte, V. Bordeau, B. Fromenty, 2022, Proceedings of the National Academy of Sciences.

Comparative Efficacies of Antibiotics in a Rat Model of Meningoencephalitis Due to Listeria monocytogenes

C. Michelet, S. Leib, M. Täuber, 1999, Antimicrobial Agents and Chemotherapy.

Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study

F. Alla, B. Iung, T. Doco‐Lecompte, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Indications for surgery for elderly patients with infective endocarditis.

C. Michelet, P. Tattevin, S. Jouneau, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Simultaneous Quantitative Assay of Six HIV Protease Inhibitors, One Metabolite, And Two Non-Nucleoside Reverse Transcriptase Inhibitors in Human Plasma by Isocratic Reversed-Phase Liquid Chromatography

C. Michelet, H. Allain, C. Arvieux, 2002, Therapeutic drug monitoring.

Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy.

O. Lantz, C. Michelet, J. Guillet, 1999, AIDS.

Heart transplantation as salvage treatment of intractable infective endocarditis.

C. Chabanne, C. Michelet, J. Verhoye, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Endocarditis due to Fusarium dimerum four years after coronary artery bypass grafting.

C. Michelet, E. Guého, T. Langanay, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Undetectable HIV-1 Viral Load in the Fluid of Bullous Skin Lesion in a Patient Receiving Highly Active Antiretroviral Therapy

C. Michelet, P. Tattevin, C. Arvieux, 2008, International journal of STD & AIDS.

Diabetes in patients with pasteurellosis

C. Michelet, P. Tattevin, C. Arvieux, 2005, Scandinavian journal of infectious diseases.

Septic shock due to Yersinia enterocolitica after autologous transfusion.

C. Michelet, H. Bracq, J. Sire, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of HHV-6 in over a thousand samples: new types of infection revealed by an analysis of positive results.

C. Michelet, D. Veyer, R. Colimon, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Mitochondrial Abnormalities in Patients with HIV-HCV Co-infection as Compared to Patients with HCV Mono-infection

J. Beillot, C. Michelet, D. Guyader, 2011, HIV clinical trials.

Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France.

C. Michelet, A. Gacouin, P. Tattevin, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients.

V. Lotteau, C. Michelet, C. Arvieux, 1999, AIDS.

Ritonavir-Saquinavir Dual Protease Inhibitor Compared to Ritonavir Alone in Human Immunodeficiency Virus-Infected Patients

F. Raffi, C. Michelet, V. Sébille, 2001, Antimicrobial Agents and Chemotherapy.

The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?

C. Michelet, P. Reboul, A. Chevailler, 1998, Clinical nephrology.

New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.

M. Fontaine‐Aupart, C. Michelet, D. Boutoille, 2016, The Journal of antimicrobial chemotherapy.

Opportunistic infections occurring during highly active antiretroviral treatment

F. Raffi, C. Michelet, C. Arvieux, 1998, AIDS.

Thrombotic thrombocytopenic purpura with the acquired immunodeficiency syndrome: a pathologically documented case report.

C. Charasse, C. Michelet, Y. le Tulzo, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Increasing Incidence of Severe Epstein-Barr Virus-Related Infectious Mononucleosis: Surveillance Study

Rémi Thomas, C. Michelet, Y. le Tulzo, 2006, Journal of Clinical Microbiology.

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

H. Fleury, F. Raffi, C. Michelet, 2002, The Journal of infectious diseases.

Simultaneous Determination of 12 β-Lactam Antibiotics in Human Plasma by High-Performance Liquid Chromatography with UV Detection: Application to Therapeutic Drug Monitoring

C. Michelet, Y. le Tulzo, P. Tattevin, 2011, Antimicrobial Agents and Chemotherapy.

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study

M. Dougados, F. Tubach, X. Mariette, 2010, Arthritis research & therapy.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

[Primary cutaneous cryptococcosis in transplant recipients: a report of two cases].

C. Michelet, C. Arvieux, H. Adamski, 2005, La Revue de medecine interne.

Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings.

C. Michelet, C. Arvieux, R. Colimon, 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

S. Pol, C. Michelet, C. Pradier, 2007, Journal of viral hepatitis.

Mitochondrial Abnormalities in HIV-Infected Lipoatrophic Patients Treated With Antiretroviral Agents

F. Chapon, J. Beillot, J. Hespel, 2004, Journal of acquired immune deficiency syndromes.

Early Virologic Failure and Rescue Therapy of Tenofovir, Abacavir, and Lamivudine for Initial Treatment of HIV-1 Infection: TONUS Study

C. Katlama, C. Michelet, G. Peytavin, 2005, HIV clinical trials.

Once-Daily Dosing of Saquinavir Soft-Gel Capsules and Ritonavir Combination in HIV-1-Infected Patients (Imea015 Study)

F. Brun-Vézinet, C. Michelet, R. Farinotti, 2003, Antiviral therapy.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Simultaneous Quantitative Assay of Atazanavir and 6 Other HIV Protease Inhibitors by Isocratic Reversed-Phase Liquid Chromatography in Human Plasma

C. Michelet, H. Allain, C. Arvieux, 2005, Therapeutic drug monitoring.

Yellow fever vaccine is safe and effective in HIV-infected patients

C. Michelet, P. Tattevin, C. Arvieux, 2004, AIDS.

[Value of the string test in the diagnosis of duodenal parasitosis].

C. Michelet, J. Coulaud, C. Penalba, 1984, Bulletin de la Societe de pathologie exotique et de ses filiales.

What is the place of teicoplanin and linezolid in the treatment of prosthetic joint infections?

C. Michelet, P. Tattevin, C. Arvieux, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antibioprophylaxie en endoscopie digestive

D. Heresbach, C. Michelet, M. Barthet, 2008, Acta Endoscopica.

Silica morphogenesis by lysine-leucine peptides with hydrophobic periodicity.

Prashant S. Emani, G. Drobny, C. Michelet, 2014, Langmuir : the ACS journal of surfaces and colloids.

Short report: Incidence of yellow fever vaccine-associated neurotropic disease.

C. Michelet, H. Zeller, P. Tattevin, 2009, The American journal of tropical medicine and hygiene.

Aseptic meningitis associated with lamotrigine: report of two cases

C. Michelet, N. Nesseler, P. Tattevin, 2007, European journal of neurology.

Lookback Exercise with Imported Crimean-Congo Hemorrhagic Fever, Senegal and France

C. Michelet, H. Zeller, A. Tarantola, 2006, Emerging infectious diseases.

Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.

C. Michelet, T. Lamy, C. Dauriac, 1993, Acta haematologica.

Respiratory Manifestations of Leptospirosis: A Retrospective Study

C. Michelet, Y. Tulzo, P. Tattevin, 2005, Lung.

[Predisposing factors of community acquired bacterial meningitis (excluding neonates)].

C. Michelet, M. Revest, 2009, Medecine et maladies infectieuses.

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

R. Salamon, F. Brun-Vézinet, C. Katlama, 2017, The Journal of antimicrobial chemotherapy.

[Recurrent pericarditis during meningococcal meningitis. 2 case reports].

C. Michelet, P. Tattevin, C. Arvieux, 2004, Presse medicale.

C. Michelet, C. Leport, B. Spire, 2005, Journal of psychosomatic research.

The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.

C. Michelet, P. Tattevin, C. Arvieux, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Confusion, memory disorders, and ophthalmoparesis in a patient with AIDS

C. Michelet, P. Tattevin, D. Taussig, 2006, The Lancet.

Isolation ofBordetella bronchiseptica from a patient with AIDS

C. Michelet, N. Guiso, P. Donnio, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

[Occurrence of myasthenia in HIV infection. 2 cases].

C. Michelet, M. Tiab, C. Camus, 1993, Annales de medecine interne.

Prevalence of and risk factors for acute mountain sickness among a cohort of high-altitude travellers who received pre-travel counselling.

C. Michelet, P. Tattevin, J. Gangneux, 2014, Travel medicine and infectious disease.

False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

É. Oksenhendler, C. Katlama, D. Neau, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

F. Tubach, P. Ravaud, X. Mariette, 2010, Annals of the rheumatic diseases.

Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral‐experienced patients

F. Raffi, C. Michelet, S. Billaudel, 1998, AIDS.

Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis

K. Anstrom, C. Woods, M. Hannan, 2018 .

Twelve-Year Mortality in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Social Vulnerability. The ANRS CO8 APROCO-COPILOTE cohort

M. Carrieri, C. Protopopescu, C. Michelet, 2015, Antiviral therapy.

A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.

C. Michelet, P. Tattevin, C. Arvieux, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.

D. Neau, P. Morlat, C. Michelet, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014

P. Mordant, C. Michelet, L. Epelboin, 2016, Emerging infectious diseases.

Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults

F. Raffi, C. Michelet, G. Fätkenheuer, 2007, AIDS.

Simple Scoring System to Predict In‐Hospital Mortality After Surgery for Infective Endocarditis

F. Alla, F. Vandenesch, C. Acar, 2017, Journal of the American Heart Association.

Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.

D. Ernst, R. Fonteneau, G. Stan, 2008, IET systems biology.

immune system response of a HIV infected patient

Damien Ernst, Raphaël Fonteneau, Guy-Bart Stan, 2008 .

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trial of dexamethasone treatment for severe bacterial meningitis in adults

C. Michelet, Y. le Tulzo, É. Bellissant, 1999, Intensive Care Medicine.

Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults

D. Sexton, C. Michelet, C. Cabell, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial.

C. Michelet, D. Guyader, P. Perre, 2013, The Journal of infection.

Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes

C. Jacquelinet, C. Michelet, C. Arvieux, 1997, Antimicrobial agents and chemotherapy.

Fungal endocarditis: current challenges.

C. Michelet, O. Lortholary, P. Tattevin, 2014, International journal of antimicrobial agents.

Prevalence and Predictors of Deterioration of a Trustful Patient-Provider Relationship Among HIV-Infected Persons Treated With Antiretroviral Therapy

J. Ragnaud, F. Raffi, M. Carrieri, 2008, Journal of acquired immune deficiency syndromes.

Meningitis as a Possible Feature of the Jarisch-Herxheimer Reaction in Leptospirosis

C. Michelet, P. Tattevin, S. Jauréguiberry, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[Lyme disease: The French Infectious Diseases Society's statement].

C. Michelet, E. Caumes, D. Christmann, 2016, Medecine et maladies infectieuses.

Massive hemoptysis from iatrogenic balloon catheter rupture of pulmonary artery: successful early management by balloon tamponade.

C. Michelet, L. Siproudhis, C. Camus, 1987, Critical care medicine.

Failure of antibiotic-lock technique using daptomycin for subcutaneous injection ports in a patient on home parenteral nutrition.

C. Michelet, P. Tattevin, C. Arvieux, 2010, Journal of Infection.

Suspicion of interaction between maribavir and everolimus in a renal transplant recipient.

C. Michelet, F. Lemaitre, É. Bellissant, 2014, Transplantation.

Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.

B. Genetet, C. Michelet, A. Ruffault, 1997, AIDS research and human retroviruses.

Increased risk of renal stones in patients treated with atazanavir.

C. Michelet, P. Tattevin, C. Arvieux, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Should we systematically perform central nervous system imaging in patients with Whipple's endocarditis?

C. Michelet, P. Tattevin, C. Arvieux, 2010, The American journal of medicine.

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.

J. Heitman, G. Klintmalm, K. Gupta, 2007, The Journal of infectious diseases.

Deep brain stimulation hardware-related infections: a report of 12 cases and review of the literature.

C. Haegelen, C. Michelet, P. Tattevin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine

F. Raffi, C. Michelet, V. Sébille, 1999, Clinical pharmacology and therapeutics.

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

V. de Lédinghen, Y. Yazdanpanah, D. Neau, 2018, HIV medicine.

Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.

Suzanne R. Bradley, K. Anstrom, M. Hannan, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Imported Crimean-Congo Hemorrhagic Fever

C. Michelet, H. Zeller, A. Tarantola, 2005, Journal of Clinical Microbiology.

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

K. Anstrom, C. Woods, M. Hannan, 2016, Journal of the American Heart Association.

Abstracts cont.

C. Michelet, P. Tattevin, C. Arvieux, 2005, Clinical Microbiology and Infection.

Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry

S. Bertrais, C. Michelet, P. Calès, 2012, Journal of viral hepatitis.

Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)

K. Anstrom, C. Woods, M. Hannan, 2023, Infectious Diseases and Therapy.

Granulomatous Lymphadenitis as a Manifestation of Q Fever

C. Michelet, P. Guggenbuhl, P. Tattevin, 2003, Emerging infectious diseases.

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial

C. Katlama, M. Shoai, H. Melliez, 2018, The Journal of antimicrobial chemotherapy.